PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 144 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $315,227 | +66.8% | 11,413 | -49.1% | 0.01% | +14.3% |
| Q3 2022 | $189,000 | -18.5% | 22,421 | +128.9% | 0.01% | -36.4% |
| Q1 2022 | $232,000 | -15.0% | 9,795 | -6.9% | 0.01% | -56.0% |
| Q1 2021 | $273,000 | -25.0% | 10,522 | -41.8% | 0.02% | -35.9% |
| Q4 2020 | $364,000 | +92.6% | 18,074 | +68.8% | 0.04% | +200.0% |
| Q2 2020 | $189,000 | +30.3% | 10,707 | -47.7% | 0.01% | +18.2% |
| Q1 2020 | $145,000 | +17.9% | 20,481 | +11.8% | 0.01% | +37.5% |
| Q4 2018 | $123,000 | -59.5% | 18,317 | -38.1% | 0.01% | -65.2% |
| Q3 2018 | $304,000 | +57.5% | 29,580 | +31.4% | 0.02% | +76.9% |
| Q1 2018 | $193,000 | -45.8% | 22,506 | +31.6% | 0.01% | -66.7% |
| Q4 2017 | $356,000 | – | 17,106 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $56,331,209 | 18.32% |
| Kynam Capital Management, LP | 1,375,000 | $31,625,000 | 4.08% |
| BVF INC/IL | 3,775,900 | $86,845,700 | 3.18% |
| Cormorant Asset Management, LP | 1,700,000 | $39,100 | 2.58% |
| RTW INVESTMENTS, LP | 4,600,799 | $105,818,377 | 2.20% |
| Ghost Tree Capital, LLC | 225,000 | $5,175,000 | 1.53% |
| 683 Capital Management, LLC | 791,000 | $18,193,000 | 1.36% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 105,486 | $2,426,178 | 1.00% |